#Disposable Syringes Market share

[marketwire]

Disposable Syringes Market - Forecast(2024 - 2030)

Disposable Syringes Market Overview:

Disposable Syringes Market size is estimated to reach $24 billion by 2030, growing at a CAGR of 6.7% during the forecast period 2023-2030. The rising demand for injectable medications and increasing adoption of telemedicine are propelling the Disposable Syringes Market growth.

Additionally, the education and training programs for healthcare providers and end-users on the proper use, handling and disposal are creating substantial growth opportunities for the Disposable Syringes Market. As per U.S. Bureau of Labor Statistics, health education specialists and community health workers are expected to grow at a significant rate of 12% by 2031, exceeding the average growth rate for all occupations. This reflects the increasing demand for these professionals and underscores their crucial role in advancing public health and wellness. These factors positively influence the Disposable Syringes industry outlook during the forecast period.

Market Snapshot:  Disposable Syringes Market - Report Coverage:

The “Disposable Syringes Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Disposable Syringes Market.

Attribute

Segment

By Type

Safety Syringes

Conventional Syringes

Prefilled Syringes

Insulin Syringes

Others

By Syringe Size

Below 5ml

5-10ml

Above 10ml

By Application  

Therapeutic Injections

Immunization Injections

Blood Sample Collection

Others

By End-User

Diagnostics Laboratories

Hospital

Pharmaceutical Industry

Blood Banks

Veterinary

Others

By Geography

North America (U.S., Canada and Mexico)

Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific)

South America (Brazil, Argentina, Chile, Colombia and Rest of South America)

Rest of the World (Middle East and Africa).

 

COVID-19 / Ukraine Crisis - Impact Analysis:

●        The COVID-19 pandemic has created a heightened demand for disposable syringes due to the urgent need for vaccination campaigns worldwide. Vaccination programs require massive quantities of syringes for administering vaccines, which has resulted in increased production and sales of disposable syringes.

●        The Ukraine crisis has disrupted the supply chain of disposable syringes, including procurement of raw materials, manufacturing and distribution. This can result in challenges in the availability and accessibility of disposable syringes, potentially leading to supply shortages and production delays.

Key Takeaways:

●        Fastest Growth of Rest of the World : Geographically, in the global Disposable Syringes Market share, Rest of the World is analyzed to grow with the highest CAGR of 7.3% during the forecast period 2023-2030. The growth is attributed to the rising healthcare expenditure and infrastructure development in emerging economies. Moreover, the increasing prevalence of chronic diseases and the growing demand for injectable medications are also fueling the market. In November 2021, Revital Healthcare (EPZ) Limited, a Kenyan medical supply manufacturer, announced that it had received nearly $4 million from the Bill & Melinda Gates Foundation to expand the production of auto-disable vaccine syringes. This funding allowed Revital to increase syringe production volume from approximately 72 million.

●        Therapeutic Injections is Leading the Market : According to the Therapeutic Injections Market forecast, the Therapeutic Injections held the largest market valuation of $5.9 billion in 2022 owing to the increasing prevalence of chronic diseases, rising demand for injectable medications and advancements in therapeutic treatments. Therapeutic injections are commonly used for administering medications for conditions such as diabetes, cancer, autoimmune diseases and others.

●        Prefilled Syringes to Register the Fastest Growth : In the Disposable Syringes Market analysis, the Prefilled Syringes segment is estimated to grow with the highest CAGR of 7.2% during the forecast period. The increasing demand for efficient and convenient drug delivery systems drives the adoption of prefilled syringes. These syringes come pre-loaded with a precise dosage of medication, eliminating the need for manual filling and reducing the risk of dosing errors. In May 2022, Terumo Corporation introduced a pre-fillable polymer syringe designed for low-dose applications. This innovative product provides a safe, user-friendly, and efficient treatment solution, catering to the needs of healthcare professionals and patients alike.

●         Adoption of  Injectable Medication : The demand for injectable medications is on the rise due to the increasing prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases and the growing aging population as well as advancements in therapeutic treatments. Injectable medications are preferred for their fast and effective delivery, precise dosing and ease of administration. In 2022, as per Drug Development & Delivery article, the growth of the injectable drug delivery is projected reach of $83.38 billion by 2030 which demonstrates the rising demand for efficient and convenient administration of medication through injectable routes.

●        Increasing Adoption of Telemedicine : Telemedicine enables patients to consult with healthcare professionals remotely, facilitating remote diagnosis, monitoring and prescription of medications. Disposable syringes play a crucial role in facilitating safe and convenient self-administration of injectable medications for chronic diseases like diabetes and autoimmune disorders. Syringes with their convenience, ease of use and disposable nature have become an essential tool in the telemedicine ecosystem which is driving the demand and growth of the market. In 2022, according to the NCBI report, over 57% of individuals aged 0-17 showed a high inclination towards using telehealth services and indicating a strong willingness among younger individuals to adopt telemedicine.

●        High Cost and Affordability Hamper the Market Growth : Expensive production processes, raw material costs and pricing limit accessibility, especially in resource-constrained settings and pose challenges for patients, healthcare providers and healthcare systems in procuring and using disposable syringes.This factor impedes the Disposable Syringes market growth.

Disposable Syringes Market Share (%) By Region, 2022

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Disposable Syringes Market. The top 10 companies in this industry are listed below:

Baxter International Inc. (BD® 60 mL Luer syringes)

Medtronic plc (i-Port AdvanceTM)

Fresenius Kabi AG (Amicus® Extracorporeal)

Terumo Corporation (PLAJEX™ COP,  Safe'n'Sound®)

B. Braun SE (Original Perfusor® Syringes, Omnifix® Lock)

Becton, Dickinson and Company. (Ultra-Fine™, Safety-Glide™)

Novo Nordisk A/S (FlexPen®, NovoPen® 5)

Retractable Technologies, Inc. (VanishPoint®, Patient Safe®)

Henke-Sass, Wolf GmbH (HSW HENKE-JECT®– two-part, HSW HENKE-JECT® Insulin)

Nipro Corporation (Dual chamber bags PLW®, Pre-filled syringes [PFS®])

Scope of the Report: 

Report Metric

Details

Base Year Considered

2022

Forecast Period

2023–2030

CAGR

6.7%

Market Size in 2030

$24 billion

Segments Covered

Type, Syringes Size, Application, End-User and Region

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Key Market Players

            Baxter International Inc.

            Medtronic plc

            Fresenius Kabi AG

            Terumo Corporation

            B. Braun SE

            Becton, Dickinson and Company.

            Novo Nordisk A/S

            Retractable Technologies, Inc.

            Henke-Sass, Wolf GmbH

            Nipro Corporation

For more Lifesciences and Healthcare Market reports, please click here

[mi-researchreports]

Disposable Syringes Market is poised to grow at a CAGR of 5.8 % by 2027. Factors driving the Disposable Syringes Market are increasing activities by various NGOs , and  rising demand for disposable syringes.

[market-insider]

Pre and Post COVID-19 Impacts on Disposable Syringes Market

The global disposable syringes market size is anticipated to reach USD 22.81 billion by 2030, registering a CAGR of 6.12% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to expand due to the increasing adoption of safety syringes, technological advancements, increasing demand for vaccines along with growing adoption of self-administration of drugs are supporting the market growth of disposable syringes.

The COVID-19 pandemic has resulted in a significant surge in demand for emergency supplies, medical disposables, medicines, and hospital equipment. As a result of COVID-19, there has been an increase in the production of COVID-19 vaccines, resulted in rise in demand for disposable syringes. In January 2020, in the U.S alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. This in turn, positively impacted the market growth and is estimated to continue to be a growth driver. Moving forward, organizations like United Nations Children's Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future.

Gain deeper insights on the market and receive your free copy with TOC now @: Disposable Syringes Market Report

Companies operating in the market are stepping up their efforts to get their products approved so that manufacturers can start mass production. One of the main areas of concern for manufacturers is the avoidance of unintentional needle stick injuries in healthcare settings. the market players are adopting various strategies, such as mergers & acquisitions, partnerships, product launches and innovations such as introduction of prefilled syringe products to strengthen their foothold in the market. Key players in the market are beefing up their R&D capabilities in order to deploy safe and simple medical practices, which is expected to enhance market growth in the near future. Some prominent players in the disposable syringes market include MEDTRONIC (Covidien); Nipro Corporation; Fresenius Kabi AG; Baxter International, Inc.; B. Braun Melsungen AG; BD.

[deshpandeisha]

The Growing Market for Disposable Syringes

The global disposable syringes market size was USD 13.07 Billion in 2021 and is expected to register a revenue CAGR of 5.8% during the forecast period, according to latest analysis by Emergen Research. Rapid technological advancements in autoinjector syringes, increasing rate of immunization, rising demand for safety syringes, substantial improvements in syringe manufacturing processes, as well as growing consumer demand from the pharmaceutical industry are factors driving marketrevenue growth.

Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1200

Competitive Terrain:

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Disposable Syringes market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.

The leading market contenders listed in the report are:

Braun Medical, Inc., Novo Nordisk, Baxter International, Inc., Fresenius Kabi AG, Becton, Dickinson and Company, Terumo Corporation, Flextronics International Vita Needle Company, UltiMed, Inc., Henke-Sass, and Covidien

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/disposable-syringes-market

Emergen Research has segmented the global Disposable Syringes market on the basis of type, application, end-use, and region:

Segments Covered in this report are:

Type Outlook (Revenue, USD Billion; 2019-2030)

Conventional Syringes

Safety Syringes

Retractable Safety Syringes

Non-retractable Safety Syringes

Application Outlook (Revenue, USD Billion; 2019-2030)

Immunization Injections

Therapeutic Injections

End-Use Outlook (Revenue, USD Billion; 2019-2030)

Hospitals

Diagnostic Laboratories

Blood Banks

Pharmaceutical Industry.

The various regions analyzed in the report include:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Objectives of the Report:

Analysis and estimation of the Disposable Syringes Market size and share for the projected period of 2022-2030

Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Disposable Syringes Market

Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments

Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1200

[5545321]

Pen Needles Market to be Worth $12.88 Billion by 2031

 Meticulous Research®—a leading global market research company, published a research report titled ‘Pen Needles Market by Type (Standard, Safety), Needle Length, Usability (Disposable, Reuse), Application (Insulin, Growth Hormone, GLP-1), Distribution Channel (Hospital Pharmacy, Retail, Online), Setting (Home Care, Hospital) — Global Forecast to 2031.’

According to this latest publication from Meticulous Research®, the pen needles market is projected to reach $12.88 billion by 2031, at a CAGR of 9.9% during the forecast period. The growth of this market is driven by factors such as the rising prevalence of diabetes, growing demand for self-administration of drugs, advancements in technology, and rising healthcare expenditure. Moreover, the preference for pen needles over vials and syringes, favorable reimbursement policies, and emerging economies are expected to offer significant market growth opportunities.

However, concerns regarding needlestick injuries restrain the market’s growth. Additionally, the reuse of pen needles, limited access to healthcare in developing nations, and lack of awareness about proper usage of pen needles pose challenges to the market’s growth.

Key Players

The key players operating in the pen needles market are Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Owen Mumford Limited (U.K.), B. Braun Melsungen AG (Germany), Terumo Group (Japan), Allison Medical, Inc. (U.S.), Cardinal Health, Inc. (U.S.), UltiMed, Inc. (U.S.), Hindustan Syringes & Medical Devices Ltd (India), and Nanchang YiLi Medical Instrument Co.,LTD (China).

Pen Needles Market: Future Outlook

The pen needles market is segmented based on Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm & Above), Usability (Single Use/Disposable, Reusable), Application (Insulin Therapy, Growth Hormone Therapy, GLP-1 Therapy, Other Applications), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Healthcare Setting (Home Care, Hospitals & Clinics, and Other Healthcare Settings), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

Based on type, the pen needles market is segmented into standard pen needles and safety pen needles. In 2024, the safety pen needles segment is expected to account for the larger share of the pen needles market. The large market share of this segment can be attributed to the advantages provided by safety pen needles, including reduced risk of needlestick injuries, assured delivery of the full medication dose in a safe manner, and enhanced control during the injection process with clear visibility of the sterile needle. Additionally, the incorporation of safety shields in safety pen needles further contributes to the segment's significant market share.

Based on needle length, the pen needles market is segmented into 4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm & above. In 2024, the 4 mm segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the advantages offered by 4 mm needles, such as minimal pain and discomfort during insulin injections. Furthermore, companies in the pen needles market are focusing on improving their product portfolios through the introduction of innovative offerings. For instance, in September 2022, Terumo Group (Japan) launched FineGlide, a sterile pen needle designed for patients requiring insulin injections or other forms of self-medication.

Based on usability, the pen needles market is segmented into single-use/disposable and reusable. In 2024, the single-use/disposable segment is expected to account for the larger share of the pen needles market. The large market share of this segment can be attributed to technological advancements in insulin delivery devices and growing awareness regarding hygiene and needlestick injuries.

Based on application, the pen needles market is segmented into insulin therapy, growth hormone therapy, GLP-1 therapy, and other applications. In 2024, the insulin therapy segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the rising demand and awareness of insulin therapy, driven by the high prevalence of diabetes. For instance, according to the International Diabetes Federation, the global diabetic population reached 537 million in 2021. Projections indicate an increase to 643 million by 2030 and 783 million by 2045.

Based on distribution channel, the pen needles market is segmented into hospital pharmacies, retail pharmacies, and online channels. In 2024, the retail pharmacies segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the advantages provided by retail pharmacies compared to other distribution channels. Retail pharmacies offer patients the convenience of accessing pen needles without the need for a prescription, thereby simplifying diabetes management for individuals.

Based on healthcare setting, the pen needles market is segmented into home care, hospitals and clinics, and other healthcare settings. In 2024, the home care segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the growing awareness of diabetes management and the rising number of diabetes cases. Additionally, the adoption of pen needles in home care settings enables individuals to manage their healthcare independently. By self-administering medications, individuals gain greater control over their treatment, seamlessly integrating it into their daily routines. This autonomy often leads to improved medication adherence and better overall health outcomes.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Austria, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, South Africa, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the pen needles market, followed by Europe and Asia-Pacific. Furthermore, in 2023, the U.S. is expected to be the largest market shareholder in North America. North America’s major market share is attributed to the highly developed healthcare infrastructure and the presence of major market players such as Becton, Dickinson and Company (U.S.), and Cardinal Health, Inc. (U.S.).

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5796

Key questions answered in the report:

· Which are the high-growth market segments in terms of type, needle length, usability, application, distribution channel, healthcare setting, and region/country?

· What was the historical market size for pen needles across the globe?

· What are the market forecasts and estimates for 2024–2031?

· What are the major drivers, restraints, and opportunities in the global pen needles market?

· Who are the major players in the global pen needles market?

· What is the competitive landscape like, and who are the market leaders in the global pen needles market?

· What are the recent developments in the pen needles market?

· What strategies are adopted by the major players in the pen needles market?

· What are the geographical trends and high-growth regions/countries?

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

[focusedmarketinsights]

The global syringes and needles market has experienced a surge in demand, driven primarily by factors such as a rising geriatric population, heightened consumer awareness, the prevalence of chronic diseases, and the burgeoning use of syringes and needles for diabetes management. Further propelling the market's growth are technological advancements, the proliferation of new product launches, robust healthcare infrastructure, intensive R&D initiatives, the presence of leading vendors, and supportive governmental policies.

In a more detailed breakdown, as of 2023, syringes command a market share of 66.89%, with predictions indicating an upward trajectory at a CAGR of 8.16%. This growth can be attributed to the escalating demand for disposable syringes fueled by aggressive immunization and vaccination drives. Additionally, adults constitute the largest patient segment, capturing a 69.25% market share in 2023 and projected to achieve 70.16% by 2029. This is largely due to the proliferation of chronic diseases among adults and the spike in diabetic cases.

[tejalbele-2024]

Insulin Syringes Market to Reach $2.40 Bn, Globally, by 2030 at 4.4% CAGR: Allied Market Research

Allied Market Research recently published a report, titled, "Insulin Syringes Market by Syringe Size (3/10 cc Syringe (0.3ml), 1/ 2 cc Syringe (0.5ml), 1cc syringe (1ml), and Others), Disease (Type-1 Diabetes and Type-2 Diabetes), End User (Hospital & Clinics, Homecare Settings, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030". As per the report, the global insulin syringes industry was pegged at USD 1.56 billion in 2020, and is expected to reach USD 2.40 billion by 2030, growing at a CAGR of 4.4% from 2021 to 2030.

𝐅𝐨𝐫 𝐑𝐢𝐠𝐡𝐭 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞 𝐚𝐧𝐝 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-sample/3740

𝐌𝐚𝐣𝐨𝐫 𝐝𝐞𝐭𝐞𝐫𝐦𝐢𝐧𝐚𝐧𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐫𝐨𝐰𝐭𝐡

Increase in prevalence of diabetes, surge in the geriatric population, and rise in healthcare expenditure have boosted the growth of the global insulin syringes market. However, high price of insulin and the availability of alternative modes of insulin delivery hinder the market growth. On the contrary, high growth potential in developing countries is expected to open new opportunities for the market players in the future.

𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐬𝐜𝐞𝐧𝐚𝐫𝐢𝐨:

The Covid-19 pandemic led to a lockdown and imposed social distancing measures across several countries. The lockdown disrupted the supply chain, production, and distribution. Patients with high blood pressure and diabetes are at higher risk of getting affected by the virus. Thus, the demand for insulin administration surged during the pandemic. The type-2 diabetes segment to manifest the highest CAGR through 2030

By disease, the type-2 diabetes segment is estimated to portray the highest CAGR of 4.9% during the forecast period. In addition, the segment held the largest share in 2020, accounting for nearly three-fifths of the market, owing to rise in case of type 2 diabetes across the world. The research also analyzes the type-1 diabetes segment.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 : https://www.alliedmarketresearch.com/insulin-syringes-market/purchase-options

𝐓𝐡𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐝𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐝 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭

By end user, the hospital & clinics segment held the largest share in 2020, contributing to nearly half of the market. In addition, the segment is projected to manifest the highest CAGR of 5.3% during the forecast period, owing to rise in prevalence of chronic diseases such as diabetes and increase in elderly population. The report also analyzes the segments including homecare and others.

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐡𝐞𝐥𝐝 𝐭𝐡𝐞 𝐥𝐢𝐨𝐧'𝐬 𝐬𝐡𝐚𝐫𝐞

By region, the market across North America held the largest share in 2020, accounting for nearly two-fifths of the market. This is due to high expenditure on R&D, well-established healthcare infrastructure, and presence of major players & their product availability. However, the market across Asia-Pacific is expected to register the highest CAGR of 6.5% during the forecast period, owing to improvement in R&D facilities, rapidly developing economic conditions, and disposable income.

𝐃𝐨 𝐘𝐨𝐮 𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲 𝐎𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭? 𝐀𝐬𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/3740

𝐌𝐚𝐣𝐨𝐫 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬

▪️ Novo Nordisk A/S ▪️ Abbott Laboratories ▪️ Biocon Ltd. ▪️ Cardinal Health Inc. ▪️ Terumo Corporation ▪️ Eli Lilly and Company ▪️ Beckton and Dickinson Company ▪️ Nipro Medical Corporation ▪️ Medline Industries ▪️ Hindustan syringe and medical device Ltd.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com/reports-store/life-sciences Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

[blog-site-for-market-research]

Understanding Consumer Preferences in the Dental Industry Market: Research Analysis

Market Overview –

The market for dental products is expected to grow at a compound annual growth rate (CAGR) of 7.1% from 2022 to 2032, or roughly USD 67.1 billion.

The dental industry market encompasses a wide range of products and services related to oral health, including dental equipment, supplies, services, and treatments. With oral health recognized as an integral part of overall well-being, the dental industry plays a crucial role in providing preventive, restorative, and cosmetic dental care to individuals of all ages.

The dental industry market, particularly in dental equipment, is experiencing steady growth. Technological advancements have led to the development of sophisticated dental equipment, enhancing diagnostic accuracy and treatment efficacy. Rising demand for dental services, coupled with increasing disposable income, is driving the adoption of advanced equipment, fueling market expansion.

Market growth is driven by several factors, including increasing awareness of oral health, growing disposable income, and advancements in dental technology and treatments. As people prioritize aesthetics and oral hygiene, there is a growing demand for dental services such as cleanings, whitening, and orthodontic treatments to enhance smiles and maintain oral health.

Technological innovations in the dental industry are shaping the market, offering new treatment modalities, materials, and digital solutions to improve patient outcomes and streamline workflow processes for dental professionals. From digital imaging and CAD/CAM technology to laser dentistry and 3D printing, these advancements enhance diagnostic accuracy, treatment precision, and patient comfort.

Moreover, the aging population and the prevalence of dental conditions such as cavities, gum disease, and tooth loss are driving market growth, as older adults seek comprehensive dental care to maintain oral function and appearance. Additionally, the rising popularity of cosmetic dentistry and dental tourism is expanding the global reach of the dental industry, creating opportunities for growth and innovation.

However, challenges such as access to dental care, affordability, and workforce shortages pose obstacles to market growth. Addressing these challenges requires collaboration between stakeholders, including dental professionals, policymakers, insurers, and technology vendors, to develop sustainable solutions and improve oral health outcomes for populations worldwide

Segmentation –

Discipline, Consumables, and End User are the three segments that make up the global dental industry market.

The global dental industry market has been classified by product into disciplines, consumables, and end users. Due to an increase in root canal therapy, the endodontics segment has the greatest market share in 2019.

Resin composites, dental biomaterial, dental aesthetic, endodontic supplies, gingival retraction material, whitening material, denture adhesive, dental imprint, dental burs, and dental syringe comprise the worldwide dental industry market by consumables. Because resin composites are widely utilized in dental decay treatment, the resin composites segment dominated the consumables segment.

Hospitals & clinics, specialized dental facilities, and dental academic and research institutes make up the worldwide dental industry market by end user. The dentistry industry's expansion is further aided by the availability of trained dental practitioners and improved treatment facilities in hospitals and clinics.

Regional Analysis –

Regional analysis of the dental industry market unveils diverse trends and patterns across different regions worldwide. In North America, the market is characterized by advanced technology adoption, high dental care expenditure, and a strong emphasis on cosmetic dentistry.

The United States, in particular, leads the region with a large market size driven by factors such as a well-established healthcare system and a growing elderly population requiring dental treatments. In Europe, the market is influenced by stringent regulatory standards, leading to a focus on quality and safety in dental products and procedures.

Countries like Germany and the UK are major contributors to the European dental industry, with a robust dental infrastructure and a high level of awareness regarding oral health. In the Asia-Pacific region, increasing disposable incomes, improving healthcare infrastructure, and rising dental tourism drive market growth. Countries like China, Japan, and South Korea are key players in this region, witnessing a surge in demand for both preventive and cosmetic dental services.

Latin America showcases a growing demand for dental care, spurred by rising disposable incomes and increasing awareness of oral hygiene. The Middle East and Africa witness expanding dental markets, driven by improving healthcare facilities and rising dental health awareness campaigns. Understanding these regional dynamics is crucial for stakeholders in the dental industry to tailor their strategies and offerings according to the unique needs and preferences of each market, ensuring sustained growth and success.

Key Players –

Dental Industry prominent players are Abano Healthcare Group Limited, 3M, Allergan plc, Coltene Group, Dentsply Sirona, Coast Dental, Dental Service Group, Axis Dental, and Henry Schein, Inc., among others

Related Reports –

Urinalysis Test

Celiac Disease Treatment

Healthcare Enterprise Software

Amniotic Membrane

For more information visit at MarketResearchFuture

[chemicalresearchupdates]

Sulfone Polymer Market: Innovations and Advancements in Electronic Components

Sulfone polymer, also known as polysulfone, is a highly temperature resistant material used for its strength, durability and resistance to chemicals. It is commonly used to produce medical devices such as dialyzers, blood filters and artificial organs owing to its bio-compatibility. Sulfone polymers do not leach any toxic chemicals and can withstand high temperatures, making them ideal for uses in the medical industry.

The global sulfone polymer market is estimated to be valued at US$ 2.65 Bn in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Increasing Demand from Medical Industry The key market opportunity for sulfone polymer market lies in the increasing demand from the medical industry. Sulfone polymers are widely used in medical devices such as dialyzers, syringes, blood oxygenators, contact lenses and surgical instruments owing to their bio-compatibility and chemical resistance. Growing elderly population and increasing healthcare expenditure is expected to boost the demand for various medical devices. As sulfone polymers are an integral part of manufacturing these devices, increasing demand from the medical industry will have a positive impact on the growth of the sulfone polymer market over the forecast period. Advantages of sulfone polymers such as non-toxicity, chemical resistance and heat stability make them suitable for critical medical applications. Porter’s Analysis

Threat of new entrants: The threat of new entrants in the sulfone polymer market is moderate. High capital requirements and established brand value of existing players creates barriers for new players.

Bargaining power of buyers: The bargaining power of buyers is high due to availability of substitutes. Buyers can negotiate on price and demand customized products.

Bargaining power of suppliers: The bargaining power of suppliers is moderate. Suppliers of raw materials like bisphenol-A and PBT have moderate switching costs.

Threat of new substitutes: The threat of substitutes is high due to availability of alternative polymers like polyetherketone, polyetherimide and polyphenylene sulfide in the market.

Competitive rivalry: The competitive rivalry is high among the key players to gain major market share. SWOT Analysis

Strength: High heat and chemical resistance properties make sulfone polymers suitable for use in automotive, electronics and healthcare industries. Excellent dimensional stability and low moisture absorption characteristics provides durability.

Weakness: High production cost of sulfone polymers compared to alternatives limits its use in price sensitive applications. Complex production process poses challenge for mass production.

Opportunity: Growing demand for lightweight and durable polymers from automotive and aerospace industries due to stringent regulations creates market opportunity. Increasing R&D on polymer blends can help utilize properties efficiently.

Threats: Volatility in price of crude oil poses threat to raw material supply and price fluctuations. Stringent environmental regulations regarding production waste disposal can increase compliance cost. Key Takeaways

The global sulfone polymer market is expected to witness high growth during the forecast period of 2023-2030. The market is expected to reach a value of US$ 4.45 Bn by 2030 expanding at a CAGR of 9.3% from 2023 to 2030.

The Asia Pacific region dominates the global sulfone polymer market with over 35% share in 2023 in terms of value. China leads the Asia Pacific sulfone polymer market due to presence of large automotive and electronics industry. Key players operating in the sulfone polymer market are Solvay, BASF, Sumitomo, Evonik, Sabic, Ensinger GmbH, PolyOne Corporation, RTP Company, Mitsubishi Chemical, and Omnia Plastica SPA. Solvay and BASF capture over 35% of the global sulfone polymer market share. Solvay offers a wide range of sulfone polymers under the name Udel P-1700, Udel P-1750, Udel P-1800 for automotive, medical and electronics applications.

[infinitiresearch]

Prefilled Syringes Market| Analysis, Growth and Forecast, 2023 – 2027

Originally published on Technavio: Prefilled Syringes Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2023-2027

The Prefilled Syringes Market is undergoing substantial analysis, focusing on the regions of North America, Europe, Asia, and the Rest of the World (ROW), including key countries like the US, Canada, Germany, the UK, and China. The market analysis for the forecast period of 2023-2027 provides comprehensive insights into the factors influencing the growth and dynamics of the prefilled syringes sector.

**North America** emerges as a prominent market for prefilled syringes, with the US and Canada at the forefront of adoption. The region's market growth is attributed to factors such as an aging population, increasing prevalence of chronic diseases, and a robust healthcare infrastructure. Additionally, the emphasis on patient safety and the convenience offered by prefilled syringes contribute to their widespread use in this region.

**Europe** is a significant player in the prefilled syringes market, with Germany and the UK driving adoption. The region benefits from a well-established healthcare system and a growing awareness among healthcare professionals and patients about the advantages of prefilled syringes. Stringent regulations focusing on the safety and efficacy of drug delivery systems further fuel the market growth in Europe.

The **Asian market**, particularly in countries like China, is experiencing a surge in demand for prefilled syringes. Factors such as a rising geriatric population, increasing healthcare expenditures, and a growing focus on vaccination programs contribute to the expanding market share in Asia. The adoption of innovative drug delivery technologies and a shift towards self-administration of drugs also drive the market dynamics in this region.

The **Rest of the World (ROW)**, comprising various emerging markets, demonstrates a growing interest in prefilled syringes. Factors such as improving healthcare infrastructure, rising disposable income, and increasing awareness about advanced drug delivery methods contribute to the market growth in these regions.

To Learn deeper into this report , View Sample PDF

The forecast for the prefilled syringes market indicates a positive trajectory, driven by factors like technological advancements, the need for convenient drug delivery systems, and a rising preference for self-administration of medications. As the healthcare landscape continues to evolve, prefilled syringes are expected to play a pivotal role in ensuring safe and effective drug administration globally.

For more information please contact.

[manthanwwww]

Aseptic Processing Market

Aseptic Processing Market Size, Share, Trend, Growth and Global Opportunity Analysis and Industry Forecast, 2023-2030.

Overview

Global Aseptic Processing Market was valued at USD 9.72 billion in 2022 and is slated to reach at USD 14.57 by 2030 at a CAGR of 5.23% from 2023-2030.

 The leading players operating in the Aseptic Processing Market are also studied in the report to provide readers with a comprehensive overview of the competitive landscape in the market. The major strategies used by leading players are studied in the report to provide readers with an idea of what works and what doesn’t, in the Aseptic Processing Market. Individual key players are analyzed in detail in the report in order to elaborate on their regional analysis and product catalog, providing a clear overview of each major player operating in the Aseptic Processing Market.

Key Players:

 Robert Bosch GmbH,

DuPont,

Tetra Laval Group,

Merck KGaA,

Spx Flow,

Request A Free Sample: https://qualiketresearch.com/reports-details/Aseptic-Processing-Market

Market Segmentation: Global Aseptic Processing Market is segmented into Type, Application, and Material. By Type such as Cartons, Bottles and Cans, Bags and Pouches, Vials and Ampoules, Pre- Filled Syringes, Other, Trays, Containers, Bag-in-box Packging, Cups. By Application such as Food, Convenience Food, Meat and Seafood, Fruits and Vegetables, Beverages, Milk and Dairy Products, Fruit Juices, Pharmaceutical, Others.

Regional Analysis: Global Aseptic Processing Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The aseptic processing sector is anticipated to grow at the quickest rate in North America. The development of novel packaging techniques and the rise in demand for processed items are further factors contributing to the expansion of this market. Additionally, the emergence of novel drugs and an increase in disposable income have promoted market expansion.

 About Us:

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers.

QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence.

QualiKet Research strive hard to simplify strategic decisions enabling you to make right choice. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition. Our experts provide deep insights which is not available publicly that enables you to take bold steps.

Contact Us:

     6060 N Central Expy #500 TX 75204, U.S.A

     sales@qualiketresearch.com

     +1 214 660 5449

     1201, City Avenue, Shankar Kalat Nagar,

     Wakad, Pune 411057, Maharashtra, India

     sales@qualiketresearch.com

     +91 9284752585

     Sharjah Media City , Al Messaned, Sharjah, UAE.

     sales@qualiketresearch.com

     +91 9284752585

[alicesara611]

The Impact of Technological Advancements on the Closed System Drug Transfer Device Market By 2023 to 2030

The global closed system drug transfer device (CSTD) market is expected to grow from US$ 1519.51 million in 2023 to US$ 5206.9 million by 2030, at a CAGR of 22.79%. Closed System Drug Transfer Devices (CSTDs) are medical devices that are used to transfer hazardous drugs from one container to another without exposing healthcare workers to the drug or its aerosolized particles. CSTDs are becoming increasingly popular, as they can help to reduce the risk of occupational exposure to hazardous drugs, which can lead to a number of health problems, including cancer, reproductive problems, and respiratory problems.

The closed system drug-transfer device, or closed system transfer device (CSTD), is a widely used device that stops dangerous environmental toxins from entering the system. Additionally, it limits the amount of dangerous drug vapor concentrations that can exit the system. Currently, there are two basic design approaches used in closed system transfer devices: one that incorporates physical barriers and another that uses air-cleaning technologies. The closed system transfer devices (CSTD) market is anticipated to grow during the forecast period as a result of the growing emphasis on enhancing the general safety of healthcare personnel who are in charge of administering and synthesizing hazardous medications.

Request A Report Sample To Gain Comprehensive Insights! https://bit.ly/3sfUMY9

Closed system drug transfer devices (CSTDs) are medical devices that protect healthcare workers and patients from exposure to hazardous drugs. CSTDs create a closed system during the preparation, administration, and disposal of hazardous drugs, minimizing the risk of drug aerosols, drug contamination, sharps exposure, and hazardous drug exposure.

Key Takeaways:

The global closed system drug transfer device (CSTD) market is expected to grow from US$ 1519.51 million in 2023 to US$ 5206.9 million by 2030, at a CAGR of 22.79%.

The growth of the market is attributed to the increasing use of CSTDs to reduce the risk of exposure to hazardous drugs and other hazardous substances, as well as the rising prevalence of cancer and other chronic diseases.

The oncology segment is expected to account for the largest share of the market during the forecast period, due to the increasing use of CSTDs for the administration of chemotherapy drugs.

The North American region is expected to dominate the market during the forecast period, owing to the early adoption of CSTDs in the region and the presence of a large number of key players.

Regional Outlook:

The global CSTD market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America is expected to remain the largest market for CSTDs during the forecast period, owing to the early adoption of CSTDs in the region and the presence of a large number of key players.

Europe is expected to be the second-largest market for CSTDs during the forecast period, due to the increasing awareness of the benefits of CSTDs and the rising prevalence of chronic diseases in the region.

The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period, owing to the increasing prevalence of cancer and other chronic diseases, as well as the rising demand for CSTDs in emerging economies such as India and China.

Key Players:

The key players in the global CSTD market include:

BD Medical, Inc.

ICU Medical, Inc.

Equashield, LLC

Hospira

Chemolock

B. Braun Medical Inc.

Teva Medical Ltd.

Corvida Medical

OnGuard

Baxter International Inc.

Medline Industries, Inc.

Segmentation:

The global CSTD market is segmented based on type, application, and end user.

By Type:

Closed vial transfer devices

Closed syringe transfer devices

Closed IV admixtures transfer devices

Others

By Application:

Oncology

Non-oncology

By End User:

Hospitals

Ambulatory surgical centers

Home healthcare

Others

[vanshika393]

Closed System Transfer Devices Market- Share and Demand Analysis with Size, Growth Drivers and Forecast to 2030 | Credence Research

The latest market report published by Credence Research, Inc. “Global Closed System Transfer Devices Market: Growth, Future Prospects, and Competitive Analysis, 2023 – 2030. The global Closed System Transfer Devices Market has been steadily growing in recent years and is predicted to grow at a 20.30% CAGR between 2023 and 2030. The market is anticipated to be worth USD 4934.0 million by 2030, up from USD 1124.8 million in 2022.

The Closed System Transfer Devices (CSTD) Market refers to the industry involved in the development, manufacturing, and distribution of specialized medical devices designed to safely transfer and handle hazardous drugs in healthcare settings. These devices are primarily used to protect healthcare workers, patients, and the environment from exposure to potentially harmful drugs, such as chemotherapy medications and other toxic substances.

Closed System Transfer Devices consist of various components, including vials, syringes, connectors, and tubing systems, all of which are designed to create a closed and sealed system for drug transfer. This closed system minimizes the risk of drug spills, aerosolization, and contamination during the preparation, administration, and disposal of hazardous drugs. It helps prevent accidental exposure, which can have serious health consequences for healthcare workers and patients.

The CSTD market has grown in response to the increasing awareness of the potential dangers associated with handling hazardous drugs and the need for stringent safety measures. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have issued guidelines and recommendations for the use of Closed System Transfer Devices to protect healthcare professionals and patients.

Closed System Transfer Devices Market Growth Factor Worldwide

The Closed System Transfer Devices (CSTD) market has witnessed substantial growth in recent years. The global demand for these advanced medical devices, designed to transfer hazardous drugs without any leakage or contamination, continues to rise rapidly. Several factors contribute to this market expansion. First and foremost, the increasing prevalence of cancer worldwide has significantly fueled the adoption of CSTDs in chemotherapy administration and drug compounding processes.

As healthcare providers prioritize patient safety and minimize the risk of exposure to harmful substances, CSTDs have emerged as a critical solution that ensures both healthcare worker protection and maximal drug efficacy. Additionally, stringent government regulations mandating the use of CSTDs further drive their market growth across various regions globally. Moreover, advancements in technology have led to more innovative CSTD designs with enhanced features such as mechanical valves and air-cleaning systems, which are highly effective at preventing hazardous drug emissions during transfer.

This continuous development propels research and development activities within the industry while fostering increased adoption rates among hospitals, clinics, ambulatory surgical centers, and pharmacies alike. Furthermore, growing awareness regarding occupational hazards associated with handling cytotoxic drugs further boosts usage rates of closed system transfer devices as a precautionary measure by care providers worldwide.

The global Closed System Transfer Devices Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

B. Braun Holding Gmbh & Co. Kg

Equashield Llc.

Fimi Opportunity Funds (Simplivia Healthcare Ltd.)

Jcb Co., Ltd. (Jms Co Ltd)

Icu Medical Inc.

Baxter International Inc

Yukon Medical, Llc.

Caragen Ltd.

Corvida Medical, Inc.

Becton, Dickinson, And Company

Browse 247 pages report Closed System Transfer Devices Market By End User (Hospitals, Oncology Centers, Pharmaceutical and Biotechnology Companies, Homecare Settings) By Drug Type (Hazardous Drugs, Non-Hazardous Drugs) By Application (Chemotherapy, Antiviral and Biological Drugs, Other Drug Classes)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030 - https://www.credenceresearch.com/report/closed-system-transfer-devices-market

The Closed System Transfer Devices (CSTD) market, which includes equipment and technologies designed to safely transfer hazardous drugs, faces several major challenges and risks:

Regulatory Compliance: CSTDs must adhere to strict regulatory guidelines and standards, such as those set forth by organizations like the U.S. Food and Drug Administration (FDA). Manufacturers and healthcare facilities must continually update and modify their devices to comply with changing regulations, which can be costly and time-consuming.

Costs: Implementing CSTDs in healthcare facilities can be expensive. The initial purchase cost, ongoing maintenance, and staff training can strain budgets. Facilities often have to weigh these costs against the potential benefits of reduced exposure risks.

Compatibility Issues: CSTDs need to be compatible with a wide range of drug containers and administration systems. Ensuring compatibility can be challenging, especially as new drugs and delivery systems are developed.

User Training: Proper training is crucial for the safe and effective use of CSTDs. Ensuring that healthcare personnel are adequately trained and consistently follow proper procedures is a challenge, as staff turnover and varying levels of experience can lead to lapses in adherence.

Product Selection: Healthcare facilities must carefully select the right CSTDs for their specific needs. With a variety of options available, including different technologies and manufacturers, making the right choice can be complex and may require extensive research.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Closed System Transfer Devices Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Closed System Transfer Devices Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Complete Report- https://www.credenceresearch.com/report/closed-system-transfer-devices-market

Visit our Website- https://www.credenceresearch.com

Related Reports- https://www.credenceresearch.com/report/cellulite-treatment-market

https://www.credenceresearch.com/report/cancer-biological-therapy-market

Browse Our Blog- https://www.linkedin.com/pulse/closed-system-transfer-devices-market-size-trends-analysis-shukla

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

[market-insider]

Single-Use Bioprocessing Market in the Quest for Efficient Biopharmaceutical Production

The global single-use bioprocessing market size is projected to reach USD 80.13 million by 2030, registering a compound annual growth rate (CAGR) of 16.24% over the forecast period, according to a new report by Grand View Research, Inc. The demand for single-use bioprocessing offerings is driven by the commercial advantages offered, including a reduction in costs and time required for bioprocessing operations. Originally used for monoclonal antibody production, single-use technologies are also gaining traction for cell and gene therapy manufacturing. As a result, broadening the scope of applications in biomanufacturing operations is likely to drive industry growth.

Single-use Bioprocessing Market Report Highlights

The simple & peripheral elements segment held the largest share in 2023 due to the significant adoption of these products as a result of a variety of customizable options available for bioprocessing applications

The upstream bioprocessing workflow segment accounted for the largest share in 2023. Continuous developments and betterment in technologies for upstream bioprocessing are driving the segment growth

North America was the leading region in 2023 due to the high R&D spending and growth of the biopharmaceutical manufacturing sector in the region

Furthermore, the presence of key players, such as Thermo Fisher Scientific, Inc. and Danaher Corp., is driving the regional market

The biopharmaceutical manufacturers end-use segment dominated the industry in 2023 and accounted for the maximum revenue share. This was due to the high demand for biologics and heavy investments in cell & gene therapy manufacturing

For More Details or Sample Copy please visit link @: Single-use Bioprocessing Market Report

Furthermore, strategic initiatives from key players are expanding the industry's growth prospects. For instance, in July 2021, Cytiva and Pall Corp. announced investment plans for capacity expansion over two years. Among other key products, more than USD 300 million were invested in single-use technologies, such as bioreactor bags for cell expansion, used to make personalized therapies and syringe filters for scientific research. Similarly, the growing adoption of single-use equipment for in-house and contract manufacturing has opened new avenues for the flow of investments in this space. The industry is witnessing significant advancements in several product portfolios, including disposable probes and sensors, stirring systems, bioreactor designs, and filtration technologies, which are expected to contribute to strong revenue growth.

The benefits offered by single-use bioprocessing systems have enabled biopharmaceutical manufacturers to offer their products faster to the market by introducing multi-product facilities, entering into partnerships, or outsourcing pipeline products for contract development and manufacturing. For instance, in January 2021, Sartorius AG partnered with RoosterBio, a leading supplier of human Mesenchymal Stem/Stromal Cells (hMSC). This collaboration aimed at advancing cell & gene therapy manufacturing by leveraging the single-use manufacturing technologies from Sartorius AG. The COVID-19 pandemic has generated new growth opportunities for key stakeholders in the industry.

[meghanester]

Micro Syringes Market Future Demand, Growth with a CAGR of ~ 7% and Attain ~USD 700 Million 2023-2035

Research Nester’s recent market research analysis on “Micro Syringes Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitor’s analysis and a detailed overview of the global micro syringes market in terms of market segmentation by type, needle type, end-user, and by region.

Increasing Administration of Precise Medicines to Promote the Global Market Share of Micro Syringes

The global micro syringes market is estimated to grow majorly on account of the demand for microliter syringes for precise drug delivery. Micro syringes are typically designed for homogeneous liquids and are used to inject fluids into patients and draw fluid from their bodies. As the syringe has a small diameter, they are not only convenient for everyday applications that require accurate liquid measuring and dispensing but also are gaining popularity in the precise, accurate microliter dosing for ophthalmic injections. Hence, with millions of intravitreal injections performed annually to address posterior segment pathologies of the eye worldwide, the demand for micro syringes and microneedles is anticipated to grow at a higher rate. Moreover, the rise in the number of clinical trials and flourishment of the pharma and biopharma sector is further expected to bring numerous growth opportunities for the market.

Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-3989

Some of the major growth factors and challenges that are associated with the growth of the global micro syringes market are:

Growth Drivers:

Expansion of the Vaccine Market

Growth in the Volume of Minimally Invasive Procedures

Challenges:

The scarcity of skilled professionals who can easily use the micro syringes that generally need special training and the dearth of trained personnel who can monitor on correct injection method, safe needle disposal, and other issues are some of the major factors anticipated to hamper the global market size of micro syringes. Moreover, the stringent guidelines developed for the use of safety-engineered syringes are also expected to hinder the growth of the market.

Access our detailed report at:

By needle type, the global micro syringes market is segmented into fixed, removable. The removable segment is to garner the highest revenue by the end of 2035 by growing at a significant CAGR over the forecast period. The rise in the number of applications requiring elevated temperatures up to 115 ºC (239 ºF) is anticipated to boost the segment growth as the removable needle and microliter syringe play a crucial role in such applications. This type of needle is reusable and is available with custom lengths and different point styles, hence they are widely preferred in many laboratory research works.

Request for customization @ https://www.researchnester.com/customized-reports-3989

Moreover, the laboratories segment in the end-user segment is anticipated to garner the highest share of 35%, owing to the increasing laboratory research activities worldwide.

By region, the North American micro syringes market is to generate the highest revenue by the end of 2035. This growth is anticipated by increasing expansion in the research& development activities in the region’s pharmaceutical, biopharmaceuticals, and other life science-related fields. The constant emphasis on the development of drugs together with soaring investments in the R&D in analytical techniques are further expected to boost the regional market growth.

The micro syringes market in the European region is predicted to be the second largest region owing to the incessant advancement in the healthcare and biomedical research sector in the region.

Furthermore, the market in the Asia Pacific is estimated to hold a majority of the share of the micro syringe market by the end of 2035.

Obtain this Report @ https://www.researchnester.com/reports/micro-syringes-market/3989

This report also provides the existing competitive scenario of some of the key players of the global micro syringes market which includes company profiling of Trajan Scientific and Medical, Thermo Fisher Scientific Inc., Innovative Labor Systeme GmbH (ILS), GL Science, Inc., PerkinElmer, Inc., Agilent Technologies, Inc., Shimadzu Corporation, Avantor, Inc., ITO Corporation, Merck KGaA, and others.     

About Us

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives to take wise decisions for their future marketing strategy, expansion, investment, etc. We believe every business can expand to its new horizon, provided the right guidance at the right time is available through strategic minds. Our out of box thinking helps our clients to take wise decisions to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[5545321]

Pen Needles Market to be Worth $12.88 Billion by 2031

Meticulous Research®—a leading global market research company, published a research report titled ‘Pen Needles Market by Type (Standard, Safety), Needle Length, Usability (Disposable, Reuse), Application (Insulin, Growth Hormone, GLP-1), Distribution Channel (Hospital Pharmacy, Retail, Online), Setting (Home Care, Hospital) — Global Forecast to 2031.’

According to this latest publication from Meticulous Research®, the pen needles market is projected to reach $12.88 billion by 2031, at a CAGR of 9.9% during the forecast period. The growth of this market is driven by factors such as the rising prevalence of diabetes, growing demand for self-administration of drugs, advancements in technology, and rising healthcare expenditure. Moreover, the preference for pen needles over vials and syringes, favorable reimbursement policies, and emerging economies are expected to offer significant market growth opportunities.

However, concerns regarding needlestick injuries restrain the market’s growth. Additionally, the reuse of pen needles, limited access to healthcare in developing nations, and lack of awareness about proper usage of pen needles pose challenges to the market’s growth.

Key Players

The key players operating in the pen needles market are Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Owen Mumford Limited (U.K.), B. Braun Melsungen AG (Germany), Terumo Group (Japan), Allison Medical, Inc. (U.S.), Cardinal Health, Inc. (U.S.), UltiMed, Inc. (U.S.), Hindustan Syringes & Medical Devices Ltd (India), and Nanchang YiLi Medical Instrument Co.,LTD (China).

Pen Needles Market: Future Outlook

The pen needles market is segmented based on Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm & Above), Usability (Single Use/Disposable, Reusable), Application (Insulin Therapy, Growth Hormone Therapy, GLP-1 Therapy, Other Applications), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Healthcare Setting (Home Care, Hospitals & Clinics, and Other Healthcare Settings), and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

Based on type, the pen needles market is segmented into standard pen needles and safety pen needles. In 2024, the safety pen needles segment is expected to account for the larger share of the pen needles market. The large market share of this segment can be attributed to the advantages provided by safety pen needles, including reduced risk of needlestick injuries, assured delivery of the full medication dose in a safe manner, and enhanced control during the injection process with clear visibility of the sterile needle. Additionally, the incorporation of safety shields in safety pen needles further contributes to the segment's significant market share.

Based on needle length, the pen needles market is segmented into 4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm & above. In 2024, the 4 mm segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the advantages offered by 4 mm needles, such as minimal pain and discomfort during insulin injections. Furthermore, companies in the pen needles market are focusing on improving their product portfolios through the introduction of innovative offerings. For instance, in September 2022, Terumo Group (Japan) launched FineGlide, a sterile pen needle designed for patients requiring insulin injections or other forms of self-medication.

Based on usability, the pen needles market is segmented into single-use/disposable and reusable. In 2024, the single-use/disposable segment is expected to account for the larger share of the pen needles market. The large market share of this segment can be attributed to technological advancements in insulin delivery devices and growing awareness regarding hygiene and needlestick injuries.

Based on application, the pen needles market is segmented into insulin therapy, growth hormone therapy, GLP-1 therapy, and other applications. In 2024, the insulin therapy segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the rising demand and awareness of insulin therapy, driven by the high prevalence of diabetes. For instance, according to the International Diabetes Federation, the global diabetic population reached 537 million in 2021. Projections indicate an increase to 643 million by 2030 and 783 million by 2045.

Based on distribution channel, the pen needles market is segmented into hospital pharmacies, retail pharmacies, and online channels. In 2024, the retail pharmacies segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the advantages provided by retail pharmacies compared to other distribution channels. Retail pharmacies offer patients the convenience of accessing pen needles without the need for a prescription, thereby simplifying diabetes management for individuals.

Based on healthcare setting, the pen needles market is segmented into home care, hospitals and clinics, and other healthcare settings. In 2024, the home care segment is expected to account for the largest share of the pen needles market. The large market share of this segment can be attributed to the growing awareness of diabetes management and the rising number of diabetes cases. Additionally, the adoption of pen needles in home care settings enables individuals to manage their healthcare independently. By self-administering medications, individuals gain greater control over their treatment, seamlessly integrating it into their daily routines. This autonomy often leads to improved medication adherence and better overall health outcomes.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Austria, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, South Africa, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the pen needles market, followed by Europe and Asia-Pacific. Furthermore, in 2023, the U.S. is expected to be the largest market shareholder in North America. North America’s major market share is attributed to the highly developed healthcare infrastructure and the presence of major market players such as Becton, Dickinson and Company (U.S.), and Cardinal Health, Inc. (U.S.).

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5796

Key questions answered in the report:

Which are the high-growth market segments in terms of type, needle length, usability, application, distribution channel, healthcare setting, and region/country?

What was the historical market size for pen needles across the globe?

What are the market forecasts and estimates for 2024–2031?

What are the major drivers, restraints, and opportunities in the global pen needles market?

Who are the major players in the global pen needles market?

What is the competitive landscape like, and who are the market leaders in the global pen needles market?

What are the recent developments in the pen needles market?

What strategies are adopted by the major players in the pen needles market?

What are the geographical trends and high-growth regions/countries?

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research